The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • AdAlta (1AD) has been granted its second patent by the Japanese Patent Office for its lead program, AD-214
  • The company says the patent is a “valuable” addition as it will support the expansion of protected claims for AD-214 in Japan which is a major market for fibrosis-related diseases
  • The patent will expire on January 9, 2036 and adds to the list of patents received by the company in the US, Singapore and Australia
  • Shares in AdAlta last traded at 4 cents on January 10

AdAlta (1AD) has been granted its second patent by the Japanese Patent Office for its lead program, AD-214.

The second patent extends to variations in the i-body scaffold sequence related to AD-214 for treating CXCR4-related diseases or disorders.

This includes the lead indication of idiopathic pulmonary fibrosis as well as cancer, viral infections, inflammatory diseases and immune deficiency disorders, to name a few.

Thus, it extends the range and diversity of sequences analogous to AD-214 that are
protected.

“Japan is the third largest pharmaceutical market in the world and remains important to our partnering and commercialisation strategy,” CEO and Managing Director Tim Oldham said.

“This patent is a valuable, additional piece of intellectual property which enables expansion of protected claims for AD-214 in Japan, a major market for fibrosis-related diseases.”

The patent will expire on January 9, 2036 and adds to the list of patents received by the company in the US, Singapore and Australia.

Shares in AdAlta last traded at 4 cents on January 10.

1ad by the numbers
More From The Market Online
The Market Online Video

Market Open: Anthropic in blockbuster debut, but Wall Street isn’t buying the AI story

Wall Street had a new stock-market darling on last night, but it couldn’t stop investors heading for the exits.

Turners Automotive absorbs oil shock and delivers record first half

Turners Automotive Group has retained its future earnings targets despite noting a sharp fall in vehicle…
The Market Online Video

Market Open: ASX under pressure as commodity prices tumble and rate concerns return

The Australian share market is facing another difficult start this morning with ASX 200 futures pointing to a fall of around 73 points,
The Market Online Video

Market Close: Miners take a beating as ASX slides again

Well, the buyers weren’t exactly lining up to save the day on Thursday.